DocGo (NASDAQ:DCGO) Shares Down 3.1%

DocGo Inc. (NASDAQ:DCGO) shares traded down 3.1% on Monday . The company traded as low as $5.60 and last traded at $5.62. 63,496 shares traded hands during trading, a decline of 92% from the average session volume of 780,782 shares. The stock had previously closed at $5.80.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Stifel Nicolaus reissued a “buy” rating and issued a $12.00 price objective on shares of DocGo in a report on Monday, September 18th. Needham & Company LLC reissued a “buy” rating and set a $14.00 price target on shares of DocGo in a report on Monday, September 18th. BTIG Research lowered their target price on shares of DocGo from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Tuesday, September 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $13.00 price target on shares of DocGo in a research note on Monday, October 2nd. Finally, Northland Securities boosted their target price on DocGo from $15.00 to $16.00 in a report on Tuesday, August 8th.

DocGo Stock Down 1.9 %

The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.36 and a current ratio of 2.36. The stock’s fifty day simple moving average is $5.80 and its two-hundred day simple moving average is $7.89. The company has a market capitalization of $591.19 million, a price-to-earnings ratio of 64.44 and a beta of 1.05.

Insider Activity at DocGo

In other DocGo news, General Counsel Ely D. Tendler sold 10,000 shares of DocGo stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $5.29, for a total value of $52,900.00. Following the transaction, the general counsel now owns 23,088 shares in the company, valued at $122,135.52. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders sold a total of 35,334 shares of company stock valued at $237,854 over the last ninety days. Insiders own 13.78% of the company’s stock.

Institutional Investors Weigh In On DocGo

A number of large investors have recently made changes to their positions in DCGO. Deerfield Management Company L.P. Series C raised its stake in DocGo by 55.7% during the 3rd quarter. Deerfield Management Company L.P. Series C now owns 4,764,000 shares of the company’s stock valued at $25,392,000 after purchasing an additional 1,705,000 shares during the period. State Street Corp lifted its stake in DocGo by 352.2% in the second quarter. State Street Corp now owns 1,660,004 shares of the company’s stock valued at $11,852,000 after acquiring an additional 1,292,941 shares during the last quarter. Granahan Investment Management LLC bought a new stake in DocGo in the second quarter worth approximately $9,407,000. WCM Investment Management LLC increased its stake in shares of DocGo by 77.6% during the 3rd quarter. WCM Investment Management LLC now owns 2,234,689 shares of the company’s stock worth $12,000,000 after purchasing an additional 976,656 shares during the last quarter. Finally, Portolan Capital Management LLC lifted its stake in shares of DocGo by 34.8% in the 2nd quarter. Portolan Capital Management LLC now owns 2,748,902 shares of the company’s stock valued at $25,757,000 after purchasing an additional 709,553 shares during the last quarter. Institutional investors and hedge funds own 52.14% of the company’s stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.